2021 Q3 Form 10-Q Financial Statement

#000147793221008042 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q4 2020 Q3
Revenue $1.949M $1.260M $735.6K
YoY Change 165.01% 273.5% -43.55%
Cost Of Revenue $1.354M $909.2K $331.9K
YoY Change 308.02% 273.47% -59.45%
Gross Profit $595.3K $350.5K $403.7K
YoY Change 47.45% 273.57% -16.69%
Gross Profit Margin 30.54% 27.82% 54.89%
Selling, General & Admin $257.6K $534.6K $194.3K
YoY Change 32.59% -11.5% -79.19%
% of Gross Profit 43.28% 152.56% 48.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $500.00 $500.00 $510.00
YoY Change -1.96% 85.19% 88.89%
% of Gross Profit 0.08% 0.14% 0.13%
Operating Expenses $581.6K $534.6K $500.6K
YoY Change 16.18% -11.5% -46.37%
Operating Profit $13.66K -$184.2K -$96.88K
YoY Change -114.1% -63.91% -78.42%
Interest Expense $221.9K $2.176M $67.95K
YoY Change 226.54% -61.73% -101.24%
% of Operating Profit 1624.19%
Other Income/Expense, Net -$126.0K $0.00 -$2.069M
YoY Change -93.91% -6896136.67%
Pretax Income -$112.3K $2.337M -$2.166M
YoY Change -94.81% -54.83% -63.57%
Income Tax
% Of Pretax Income
Net Earnings -$112.3K $2.337M -$2.166M
YoY Change -94.81% -54.83% -63.57%
Net Earnings / Revenue -5.76% 185.56% -294.41%
Basic Earnings Per Share $0.00 -$0.03
Diluted Earnings Per Share $0.00 $33.80K -$0.03
COMMON SHARES
Basic Shares Outstanding 73.65M shares 62.80M shares
Diluted Shares Outstanding 73.65M shares 62.80M shares

Balance Sheet

Concept 2021 Q3 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $612.2K $489.6K $599.0K
YoY Change 2.2% 7.92% -18.27%
Cash & Equivalents $612.1K $489.6K $599.0K
Short-Term Investments
Other Short-Term Assets $13.85K $148.5K $124.5K
YoY Change -88.88% -40.98% 44.86%
Inventory $231.7K $189.4K $151.7K
Prepaid Expenses $13.85K $148.5K
Receivables $630.7K $292.8K $309.8K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.488M $1.120M $1.185M
YoY Change 25.61% 11.97% -9.86%
LONG-TERM ASSETS
Property, Plant & Equipment $1.836K $3.348K $3.850K
YoY Change -52.31% -85.17% -87.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.836K $3.348K $3.850K
YoY Change -52.31% -85.17% -87.93%
TOTAL ASSETS
Total Short-Term Assets $1.488M $1.120M $1.185M
Total Long-Term Assets $1.836K $3.348K $3.850K
Total Assets $1.490M $1.124M $1.189M
YoY Change 25.36% 9.83% -11.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $456.8K $279.2K $256.4K
YoY Change 78.17% -19.73% -42.6%
Accrued Expenses $1.943M $2.075M $1.823M
YoY Change 6.6% 6.3% -6.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $783.7K
YoY Change -100.0% -100.0% 110.97%
Long-Term Debt Due $654.0K $918.4K $367.0K
YoY Change 78.24% -24.1% -0.82%
Total Short-Term Liabilities $4.808M $6.681M $8.063M
YoY Change -40.38% 23.48% -26.91%
LONG-TERM LIABILITIES
Long-Term Debt $848.7K $147.9K $304.6K
YoY Change 178.61%
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $848.7K $147.9K $304.6K
YoY Change 178.61% -32.75% 13.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.808M $6.681M $8.063M
Total Long-Term Liabilities $848.7K $147.9K $304.6K
Total Liabilities $5.656M $6.829M $8.368M
YoY Change -32.4% 21.28% -25.95%
SHAREHOLDERS EQUITY
Retained Earnings -$10.94M -$11.13M
YoY Change
Common Stock $73.65K $66.37K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.422M -$5.705M -$7.179M
YoY Change
Total Liabilities & Shareholders Equity $1.490M $1.124M $1.189M
YoY Change 25.36% 9.83% -11.71%

Cashflow Statement

Concept 2021 Q3 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income -$112.3K $2.337M -$2.166M
YoY Change -94.81% -54.83% -63.57%
Depreciation, Depletion And Amortization $500.00 $500.00 $510.00
YoY Change -1.96% 85.19% 88.89%
Cash From Operating Activities -$474.5K -$186.6K -$223.8K
YoY Change 112.01% -62.25% -61.11%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 328.3K 77.16K 271.6K
YoY Change 20.89% -64.11% 246.63%
NET CHANGE
Cash From Operating Activities -474.5K -186.6K -223.8K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 328.3K 77.16K 271.6K
Net Change In Cash -146.2K -109.4K 47.76K
YoY Change -406.07% -60.81% -109.61%
FREE CASH FLOW
Cash From Operating Activities -$474.5K -$186.6K -$223.8K
Capital Expenditures $0.00
Free Cash Flow -$223.8K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
148459 USD
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
73646397 shares
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
630747 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
292835 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
231749 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
189423 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13850 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
612146 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
489560 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1488492 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1120277 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1836 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3348 USD
CY2021Q3 us-gaap Assets
Assets
1490328 USD
CY2020Q4 us-gaap Assets
Assets
1123625 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
703674 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
681439 USD
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
698980 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1024466 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
167670 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
239282 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
576774 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
809242 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
77262 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
109104 USD
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
554577 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1305106 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1696374 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1696223 USD
CY2021Q3 jksm Subscription Payable
SubscriptionPayable
499999 USD
CY2020Q4 jksm Subscription Payable
SubscriptionPayable
1055555 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4807641 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6681135 USD
CY2021Q3 jksm Notes Payable Net Of Current Portion
NotesPayableNetOfCurrentPortion
848695 USD
CY2020Q4 jksm Notes Payable Net Of Current Portion
NotesPayableNetOfCurrentPortion
147942 USD
CY2021Q3 us-gaap Liabilities
Liabilities
5656336 USD
CY2020Q4 us-gaap Liabilities
Liabilities
6829077 USD
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73646397 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66366419 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
73646 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
66366 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6113621 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4708323 USD
CY2021Q3 jksm Shares Payable
SharesPayable
2222223 shares
CY2020Q4 jksm Shares Payable
SharesPayable
4421662 shares
CY2021Q3 jksm Shares Payable Consisting Common Shares
SharesPayableConsistingCommonShares
331600 USD
CY2020Q4 jksm Shares Payable Consisting Common Shares
SharesPayableConsistingCommonShares
645192 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10941190 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11125333 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-4422323 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5705452 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1490328 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1123625 USD
CY2021Q3 us-gaap Revenues
Revenues
1949392 USD
CY2020Q3 us-gaap Revenues
Revenues
735604 USD
us-gaap Revenues
Revenues
5380615 USD
us-gaap Revenues
Revenues
2022307 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1354084 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
331863 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3767498 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
879637 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
595308 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
403741 USD
us-gaap Gross Profit
GrossProfit
1613117 USD
us-gaap Gross Profit
GrossProfit
1142670 USD
CY2021Q3 us-gaap Salaries And Wages
SalariesAndWages
324009 USD
CY2020Q3 us-gaap Salaries And Wages
SalariesAndWages
306307 USD
us-gaap Salaries And Wages
SalariesAndWages
989460 USD
us-gaap Salaries And Wages
SalariesAndWages
786004 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
257639 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
194316 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
976529 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
561154 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
581648 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
500623 USD
us-gaap Operating Expenses
OperatingExpenses
1965988 USD
us-gaap Operating Expenses
OperatingExpenses
1347158 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
13660 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-96882 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-352871 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-204488 USD
CY2021Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2020Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
6154 USD
CY2021Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
95882 USD
CY2020Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-2000866 USD
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
1171242 USD
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-3512675 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
221865 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
67945 USD
us-gaap Interest Expense
InterestExpense
735750 USD
us-gaap Interest Expense
InterestExpense
1684857 USD
CY2021Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2020Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
58642 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2021Q3 jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 USD
CY2020Q3 jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 USD
jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
160164 USD
jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-125983 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2068811 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
537014 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5191378 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-112322 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2165693 USD
us-gaap Net Income Loss
NetIncomeLoss
184143 USD
us-gaap Net Income Loss
NetIncomeLoss
-5395866 USD
CY2021Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3107 USD
CY2020Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
4315 USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-115429 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2165693 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
179828 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5395866 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73645455 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62803497 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71490810 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62531289 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73645455 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62803497 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76522446 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62531289 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5705452 USD
CY2021Q1 jksm Common Stock Issued For Debt Conversion Amount
CommonStockIssuedForDebtConversionAmount
614198 USD
CY2021Q1 jksm Common Stock Issued For Deferred Finance Cost Amount
CommonStockIssuedForDeferredFinanceCostAmount
72000 USD
CY2021Q1 jksm Sale Of Common Stock Units Amount
SaleOfCommonStockUnitsAmount
187800 USD
CY2021Q1 jksm Common Stock And Warrants Issued For Settlement Of Notes Payable Amount
CommonStockAndWarrantsIssuedForSettlementOfNotesPayableAmount
141118 USD
CY2021Q1 jksm Convertible Debt Imputed Interest
ConvertibleDebtImputedInterest
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8682 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-4699018 USD
CY2021Q2 jksm Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
6211 USD
CY2021Q2 jksm Sale Of Common Stock Units Amount
SaleOfCommonStockUnitsAmount
0 USD
CY2021Q2 jksm Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
0 USD
CY2021Q2 jksm Extinguishment Of Derivative Liability Due To Conversion
ExtinguishmentOfDerivativeLiabilityDueToConversion
72958 USD
CY2021Q2 jksm Shares Returned Under Share Lending Arrangement Amount
SharesReturnedUnderShareLendingArrangementAmount
0 USD
CY2021Q2 jksm Issuance Of Series A Preferred Stock Amount
IssuanceOfSeriesAPreferredStockAmount
0 USD
CY2021Q2 jksm Dividends On Series A Preferred Stock
DividendsOnSeriesAPreferredStock
-1208 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
305147 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4315910 USD
CY2021Q3 jksm Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
9017 USD
CY2021Q3 jksm Dividends On Series A Preferred Stock
DividendsOnSeriesAPreferredStock
-3107 USD
CY2020Q1 jksm Convertible Debt Imputed Interest
ConvertibleDebtImputedInterest
151 USD
CY2020Q1 jksm Common Stock Issued For Debt Conversion Amount
CommonStockIssuedForDebtConversionAmount
1500000 USD
CY2020Q1 jksm Sale Of Common Stock Units Amount
SaleOfCommonStockUnitsAmount
356470 USD
CY2020Q1 jksm Extinguishment Of Derivative Liability Due To Conversion
ExtinguishmentOfDerivativeLiabilityDueToConversion
606048 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5262535 USD
jksm Increasedecreaseinright Of Use Assets
IncreasedecreaseinrightOfUseAssets
9299 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
34614 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-23958 USD
jksm Right Of Use Liability
RightOfUseLiability
0 USD
jksm Right Of Use Liability
RightOfUseLiability
-9837 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-220000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-325486 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-7407409 USD
CY2020Q2 jksm Convertible Debt Imputed Interest
ConvertibleDebtImputedInterest
151 USD
CY2020Q2 jksm Sale Of Common Stock Units Amount
SaleOfCommonStockUnitsAmount
168080 USD
CY2020Q2 jksm Common Stock Issued For Deferred Finance Cost Amount
CommonStockIssuedForDeferredFinanceCostAmount
72734 USD
CY2020Q2 jksm Shares Issued Under Share Lending Arrangement Amount
SharesIssuedUnderShareLendingArrangementAmount
0 USD
CY2020Q2 jksm Shares Returned Under Share Lending Arrangementone Amount
SharesReturnedUnderShareLendingArrangementoneAmount
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2032362 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-5134082 USD
CY2020Q3 jksm Convertible Debt Imputed Interest
ConvertibleDebtImputedInterest
151 USD
CY2020Q3 jksm Sale Of Common Stock Units Amount
SaleOfCommonStockUnitsAmount
120642 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2165693 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-7178982 USD
us-gaap Net Income Loss
NetIncomeLoss
184143 USD
us-gaap Net Income Loss
NetIncomeLoss
-5395866 USD
us-gaap Depreciation
Depreciation
1512 USD
us-gaap Depreciation
Depreciation
9428 USD
jksm Imputed Interest
ImputedInterest
0 USD
jksm Imputed Interest
ImputedInterest
453 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
599052 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1594924 USD
jksm Derivative Gain Loss
DerivativeGainLoss
-1171242 USD
jksm Derivative Gain Loss
DerivativeGainLoss
3512675 USD
jksm Stock Based Compensation
StockBasedCompensation
15228 USD
jksm Stock Based Compensation
StockBasedCompensation
0 USD
jksm Gain On Settlement Of Notes Payables
GainOnSettlementOfNotesPayables
-160164 USD
jksm Gain On Settlement Of Notes Payables
GainOnSettlementOfNotesPayables
0 USD
jksm Loss On Conversion Of Notes Payable
LossOnConversionOfNotesPayable
58642 USD
jksm Loss On Conversion Of Notes Payable
LossOnConversionOfNotesPayable
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-337912 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-204320 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-42326 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38115 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
134609 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
127032 USD
jksm Increasedecreaseinright Of Use Assets
IncreasedecreaseinrightOfUseAssets
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-357078 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1009330 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-919133 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
570000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
388900 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
43300 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
905503 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
630000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1024024 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
591900 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
53605 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
89426 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
250000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
489560 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
453623 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
612146 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
598964 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
118732 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
846400 USD
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
252000 USD
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1131916 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1064474 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
122586 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
145341 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
jksm Common Stock Issued To Settle Convertible Notes Payable
CommonStockIssuedToSettleConvertibleNotesPayable
614198 USD
jksm Common Stock Issued To Settle Convertible Notes Payable
CommonStockIssuedToSettleConvertibleNotesPayable
1500000 USD
jksm Derivative Liability Recognized At Issuance Of Warrants And Conversion Option
DerivativeLiabilityRecognizedAtIssuanceOfWarrantsAndConversionOption
493670 USD
jksm Derivative Liability Recognized At Issuance Of Warrants And Conversion Option
DerivativeLiabilityRecognizedAtIssuanceOfWarrantsAndConversionOption
201208 USD
jksm Extinguishment Of Derivative Due To Warrant Exercise
ExtinguishmentOfDerivativeDueToWarrantExercise
0 USD
jksm Extinguishment Of Derivative To Conversion And Repayment
ExtinguishmentOfDerivativeToConversionAndRepayment
390383 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
72000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
72734 USD
jksm Extinguishment Of Derivative Due To Warrant Exercise
ExtinguishmentOfDerivativeDueToWarrantExercise
72958 USD
jksm Extinguishment Of Derivative To Conversion And Repayment
ExtinguishmentOfDerivativeToConversionAndRepayment
0 USD
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Note 1: Organization and Nature of Operations</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Jacksam Corporation dba Convectium is a technology company focused on developing and commercializing products of vaporizer cartridge filling &amp; capping, pre-roll filling, and other automation systems. The Company’s product line primarily consisted of the 710 Shark cartridge filling machine, the 710 Captain cartridge capping machine, the “PreRoll-ER” pre-roll &amp; cone filling machine, customizable and C-Cell cartridges, and accessories. The Company’s customers are primarily businesses operating in jurisdictions that have some form of cannabis legalization. These businesses include medical and recreational dispensaries, large and small-scale processors and growers, multi-state operators, and distributors. The Company utilizes its direct sales force, website, strategic partners’ sales force, independent sales representatives, and a wide range of referral network to sell its products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was originally organized under the laws of the State of Nevada on September 21, 1989 under the name of Fulton Ventures, Inc. Effective November 16, 2009, management at that time changed the name of Fulton Ventures, Inc. to China Grand Resorts, Inc. After the September 30, 2014 10-Q filing, the management of China Grand Resorts, Inc. abandoned the Company and its subsidiaries were taken back by Chinese national companies in China who owned them. The remaining parent company, China Grand Resorts, Inc., became a dormant company until 2016 when a new shareholder Bryan Glass became the majority shareholder and owner of the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 14, 2018 (the “Merger”), the Company’s wholly owned subsidiary, Jacksam Acquisition Corp., a corporation formed in the State of Nevada on September 11, 2018, or the Acquisition Sub, merged with and into Jacksam, a corporation incorporated in the State of Delaware in August 2013.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 5, 2018, current management merged Jacksam into the parent Company, China Grand Resorts, Inc. In connection with the transaction, current management amended our articles of incorporation to change the Company’s name from China Grand Resorts, Inc. to Jacksam Corporation dba Convectium.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Since the Merger, the Company has been operated under the control of current management and continued to operate the business of Jacksam Corporation, described herein, as our sole business.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.</p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 USD
jksm Summary Of Effect Of Potential Dilutive Issuances
SummaryOfEffectOfPotentialDilutiveIssuances
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income (loss) attributable to common stockholders</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(115,429</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,165,693</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">179,828</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5,395,866</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Preferred stock dividends</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,315</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Derivative (gain) loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,171,242</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest expense associated with convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">715,401</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income (loss) for dilutive calculation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(115,429</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2,165,693</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(271,698</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(5,395,866</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">73,645,455</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">62,803,497</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">71,490,810</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">62,531,289</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,400,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,969,136</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of common stock warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding for diluted net income (loss) per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">73,645,455</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">62,803,497</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">76,859,946</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">62,531,289</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2021Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
744444 USD
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1048524 USD
CY2021Q3 jksm Less Debt Discount And Deferred Finance Costs On Short Term Convertible Notes
LessDebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes
-167670 USD
CY2020Q4 jksm Less Debt Discount And Deferred Finance Costs On Short Term Convertible Notes
LessDebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes
-239282 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
576774 USD
CY2021Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
jksm Amortization Of Debt Discount
AmortizationOfDebtDiscount
579978 USD
CY2021Q3 jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 USD
CY2020Q3 jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 USD
jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3969136 shares
CY2020 jksm Amortization Of Debt Discount
AmortizationOfDebtDiscount
1594924 USD
us-gaap Depreciation
Depreciation
1512 USD
us-gaap Depreciation
Depreciation
9428 USD
CY2021Q1 jksm Increased Number Of Common Share
IncreasedNumberOfCommonShare
170000000 shares
CY2021Q1 jksm Preferred Stock Description
PreferredStockDescription
The Company is authorized to issue up to 10,000,000 shares of preferred stock.
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3086420 USD
CY2021Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
73578 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
250000 USD
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1388889 shares
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.18
CY2021Q3 us-gaap Share Price
SharePrice
0.18
CY2021Q3 jksm Stock Exercise Price
StockExercisePrice
0.27
jksm Common Stock Unit Subscriptions
CommonStockUnitSubscriptions
3868883 shares
CY2020 jksm Shares Remaining To Be Issued
SharesRemainingToBeIssued
2222223 shares
CY2020 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
3086420 shares
CY2020 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
-58642 USD
CY2021Q2 jksm Convertible Notes Payable Cancelled Shares
ConvertibleNotesPayableCancelledShares
860000 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1400000 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
2800000 shares
jksm Aggregate Number Beginning
AggregateNumberBeginning
9378056 shares
jksm Aggregate Exercise Price Beginning
AggregateExercisePriceBeginning
1921200 USD
jksm Weighted Average Exercise Price Beginning
WeightedAverageExercisePriceBeginning
0.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2578045 shares
jksm Aggregate Exercise Price Granted
AggregateExercisePriceGranted
562343 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.34
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
767045 shares
jksm Aggregate Exercise Price Exercised
AggregateExercisePriceExercised
337500 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.44
jksm Aggregate Number Ending
AggregateNumberEnding
11189056 shares
jksm Aggregate Exercise Price Ending
AggregateExercisePriceEnding
2646044 USD
jksm Weighted Average Exercise Price Ending
WeightedAverageExercisePriceEnding
0.24
jksm Weighted Average Remaining Contractual Life
WeightedAverageRemainingContractualLife
P2Y4M20D
CY2020 us-gaap Partners Capital Account Description Of Units Sold
PartnersCapitalAccountDescriptionOfUnitsSold
In addition to salary, the agreement provided for the option of 1,000,000 common shares of the Company, which shall vest at a rate of 28,000 share for each full one-month period worked from the Effective Date
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
192500 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
137500 USD
CY2021Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
55000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
82668 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
40256 USD
CY2021Q3 jksm Accrued Liabilities Other
AccruedLiabilitiesOther
1696374 USD

Files In Submission

Name View Source Status
0001477932-21-008042-index-headers.html Edgar Link pending
0001477932-21-008042-index.html Edgar Link pending
0001477932-21-008042.txt Edgar Link pending
0001477932-21-008042-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jksm-20210930.xsd Edgar Link pending
jksm-20210930_cal.xml Edgar Link unprocessable
jksm-20210930_def.xml Edgar Link unprocessable
jksm-20210930_lab.xml Edgar Link unprocessable
jksm-20210930_pre.xml Edgar Link unprocessable
jksm_10q.htm Edgar Link pending
jksm_10q_htm.xml Edgar Link completed
jksm_ex311.htm Edgar Link pending
jksm_ex312.htm Edgar Link pending
jksm_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending